399 related articles for article (PubMed ID: 18669522)
1. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
2. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
Goncalvez AP; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Hiramatsu K; Tadano M; Men R; Lai CJ
Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 48kDa tubulin or tubulin-like C6/36 mosquito cells protein that binds dengue virus 2 using mass spectrometry.
Chee HY; AbuBakar S
Biochem Biophys Res Commun; 2004 Jul; 320(1):11-7. PubMed ID: 15207695
[TBL] [Abstract][Full Text] [Related]
7. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
Purdy DE; Chang GJ
Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
[TBL] [Abstract][Full Text] [Related]
10. Selective phage infection mediated by epitope expression on F pilus.
Malmborg AC; Söderlind E; Frost L; Borrebaeck CA
J Mol Biol; 1997 Oct; 273(3):544-51. PubMed ID: 9356245
[TBL] [Abstract][Full Text] [Related]
11. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
[TBL] [Abstract][Full Text] [Related]
12. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production.
Limjindaporn T; Wongwiwat W; Noisakran S; Srisawat C; Netsawang J; Puttikhunt C; Kasinrerk W; Avirutnan P; Thiemmeca S; Sriburi R; Sittisombut N; Malasit P; Yenchitsomanus PT
Biochem Biophys Res Commun; 2009 Feb; 379(2):196-200. PubMed ID: 19105951
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
15. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
16. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
17. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
Gao F; Duan X; Lu X; Liu Y; Zheng L; Ding Z; Li J
Biochem Biophys Res Commun; 2010 Jan; 391(1):952-7. PubMed ID: 19962368
[TBL] [Abstract][Full Text] [Related]
18. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.
Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD
Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836
[TBL] [Abstract][Full Text] [Related]
19. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
Jaiswal S; Khanna N; Swaminathan S
Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein.
Salas-Benito J; Reyes-Del Valle J; Salas-Benito M; Ceballos-Olvera I; Mosso C; del Angel RM
Am J Trop Med Hyg; 2007 Aug; 77(2):283-90. PubMed ID: 17690400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]